60 Degrees Pharmaceuticals Announces $1M Private Placement Of 574,713 Shares At $1.74, Including Warrants
60 Degrees Pharmaceuticals Inc SXTP
$1.17
▼ -6.40%
($-0.08)
🎈 Low Float
🎢 High Beta
🗓️ Earnings Next Week
Open
$1.20
Prev Close
$1.25
Day Range
$1.11 – $1.24
52W Range
$1.05 – $8.62
Market Cap
$3.11M
Beta
2.52
EPS (TTM)
$-9.79
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2023-07-12 |
| Shares Out. | 2,660,000 |
| Website | 60degreespharma.com/ ↗ |
| Phone | 12023275422 |
| Employees | 3 |
| Revenue | $162,092 |
| Gross Profit | $76,377 |
| Net Income | -$2.1M |
| Free Cash Flow | -$8.2M |
| Total Assets | $6.8M |
| Total Liabilities | $2.0M |
| Equity | $4.7M |
About 60 Degrees Pharmaceuticals Inc
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
60 Degrees Pharmaceuticals Inc is a publicly traded company under the ticker symbol SXTP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-07-01)